New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 15, 2012
13:44 EDTDVAXFDA panel votes against backing Dynavax's Heplisav, Bloomberg reports
An FDA panel voted against recommending approval of Dynavax's hepatitis B vaccine Heplisav, saying the company provided inadequate safety data, Bloomberg reports.
News For DVAX From The Last 14 Days
Check below for free stories on DVAX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for DVAX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use